We are live on ! Find out more
MEDP icon

Medpace

310 hedge funds and large institutions have $3.05B invested in Medpace in 2020 Q3 according to their latest regulatory filings, with 62 funds opening new positions, 82 increasing their positions, 125 reducing their positions, and 27 closing their positions.

New
Increased
Maintained
Reduced
Closed

196% more call options, than puts

Call options by funds: $4.5M | Put options by funds: $1.52M

130% more first-time investments, than exits

New positions opened: 62 | Existing positions closed: 27

14% more capital invested

Capital invested by funds: $2.66B → $3.05B (+$382M)

12% more funds holding

Funds holding: 277310 (+33)

3.94% less ownership

Funds ownership: 80.91%76.97% (-3.9%)

34% less repeat investments, than reductions

Existing positions increased: 82 | Existing positions reduced: 125

Holders
310
Holders Change
+33
Holders Change %
+11.91%
% of All Funds
6.24%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.04%
New
62
Increased
82
Reduced
125
Closed
27
Calls
$4.5M
Puts
$1.52M
Net Calls
+$2.98M
Net Calls Change
+$3M

MEDP Hedge Fund Activity: Q3 2020 in Review

310 of the 4,970 institutional investors tracked by Wall St. Rank reported a position in Medpace (MEDP) for Q3 2020, worth a combined $3.05B — up 14% from $2.66B a quarter earlier.

Buyers outnumbered sellers: 62 funds opened new MEDP positions and 27 closed out — a net gain of 35 holders — while 82 added to existing stakes and 125 trimmed.

The largest buyer was Select Equity Group, opening a new position worth an estimated $21.6M. The largest seller was BlackRock, cutting an estimated $114M.

  • 310 institutional investors held Medpace (MEDP) as of Q3 2020, up from 277 in Q2 2020.
  • Funds reported $3.05B of Medpace stock for Q3 2020, up 14% quarter-over-quarter.
  • 62 funds opened new Medpace positions in Q3 2020 and 27 closed out, a net change of +35 holders.
  • The largest Medpace buyer in Q3 2020 was Select Equity Group, an estimated $21.6M added.
  • The largest Medpace seller in Q3 2020 was BlackRock, an estimated $114M sold.

Based on aggregated 13F filings for Q3 2020.